series-a
Stage
1
Investors
About
Strike Pharma is a Swedish biotech company developing in vivo CAR-T therapies for autoimmune disease and cancer based on a proprietary technology for targeted LNP delivery.
Explore Strike Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.